AP NEWS

Global Diagnostic Radiopharmaceuticals & Contrast Media Market Outlook to 2023: High Prevalence of Cancer & Heart Diseases - ResearchAndMarkets.com

August 27, 2018

DUBLIN--(BUSINESS WIRE)--Aug 27, 2018--The “Global Diagnostic Radiopharmaceuticals & Contrast Media Market - Radiopharmaceuticals Segmented by Type of Imaging, Application, Contrast Media Segmented by Application, Procedure, indication, Geography - Growth, Trends, and Forecast (2018 - 2023)” report has been added to ResearchAndMarkets.com’s offering.

The global diagnostic radiopharmaceuticals & contrast media market is expected to register a CAGR of 9% during the forecast period, 2018 to 2023.

The contrast media plays an important role in enhancing the imaging facilities for better diagnosis. There are many technical innovations in the market that are expected to contribute to the growth of the market during the forecast period. There has been an increase in the volume of the procedures that are being carried out; the CT market by itself is growing at 6% annually.

Key Highlights

High Prevalence of Cancer & Heart Diseases Short Half Life of Radiopharmaceuticals US Lead the Market in North America Region

Notable Developments in the Market

Guerbet has acquired the Accurate Medical Therapeutics. The acquisition will fuel Guerbet’s growth in interventional radiology and strengthen its current portfolio GE Healthcare expanded the MRI contrast media product range in Europe with macrocyclic agent Clariscan

Key Topics Covered

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

7. Market Segmentation

8. Competitive Landscape

9. Key Players

Bayer Healthcare GE Healthcare Guerbet Group Bracco Imaging S.p.A Mallinckrodt PLC Lantheus Holdings Inc. Amag Pharmaceuticals Inc. Medtronic Nordion Inc.

10. Future of the Market

For more information about this report visit https://www.researchandmarkets.com/research/78cmmg/global_diagnostic?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180827005427/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Contrast Media,Nuclear Medicine and Radiopharmacology

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL RADIOLOGY

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/27/2018 11:46 AM/DISC: 08/27/2018 11:46 AM

http://www.businesswire.com/news/home/20180827005427/en

AP RADIO
Update hourly